Sustained release polymer |
|||||||
| 申请号 | US15852170 | 申请日 | 2017-12-22 | 公开(公告)号 | US10047193B2 | 公开(公告)日 | 2018-08-14 |
| 申请人 | Tolmar Therapeutics, Inc.; | 发明人 | Richard L. Dunn; | ||||
| 摘要 | A polymer and a method for its preparation are provided. The polymer comprises poly(lactide), poly(lactide/glycolide) or poly(lactic acid/glycolic acid) segments bonded by ester linkages to both ends of an alkanediol core unit. The polymer is for use in a controlled release formulation for a medicament, preferably leuprolide acetate. The controlled release formulation is administered to a patient as a subcutaneous depot of a flowable composition comprising the polymer, a biocompatible solvent, and the medicament. Controlled release formulations comprising the polymer release leuprolide for treatment of prostate cancer patients over periods of 3-6 months. | ||||||
| 权利要求 | |||||||
| 说明书全文 | |||||||
QQ群二维码
意见反馈
意见反馈